Search for a trial

1 results

An open-label, fixed sequence, crossover, 1-way drug-drug-interaction study between IMB-1018972 and each of repaglinide, midazolam, paroxetine, and fluvoxamine in healthy subjects

Approved WMORecruitment stopped

The purpose of Part 1 is to investigate the effect of multiple doses of IMB-1018972 on the absorption, distribution and elimination of single doses of repaglinide and metformin and thereby understand to what extent IMB-1018972 may possibly change…

An open-label, fixed sequence, crossover, 1-way drug­-drug-­interaction study between IMB-1018972 and each of repaglinide, midazolam, paroxetine, and fluvoxamine in healthy subjects

An open-label, fixed sequence, crossover, 1-way drug-drug-interaction study between IMB-1018972 and each of repaglinide, midazolam, paroxetine, and fluvoxamine in healthy subjects